Tumor microenvironment and immune function analysis and chemotherapy prediction of SDHB in PPGL (pheochromocytoma/ paraganglioma)

Author:

Chen Danlei1,He Yi2,Yang Junfeng1

Affiliation:

1. The First People’s Hospital of Yunnan Province

2. The First Affiliated Hospital of Fujian Medical University

Abstract

Abstract Background SDHB mutations are risk factors for PPGL metastasis and poor prognosis. This study aimed to identify the SDHB gene signature and mechanisms in PPGL, and investigate its association with immunotherapy response. Method PPGL transcriptome, clinical, and single nucleotide mutation data were obtained from TCGA database. Univariate, LASSO, and multivariate Cox regression analysis was applied to construct the prognostic signature. Survival analysis, ROC curve, Cox regression analysis, and nomoplot were utilized to evaluate accuracy of the model. GO and KEGG enrichment of differentially expressed genes between risk groups were used to explore potential action mechanisms. Prognostic lncRNA co-expressed with risk signature genes were also identified. The CIBERSORT, ssGSEA, GSVA, and ESTIMATE algorithms were employed to assess the association between risk score and variations of tumor microenvironment, immune cell infiltration, immune checkpoints, and immune responses. The maftools and pRRophetic packages were enrolled to predict tumor mutation burden and drug sensitivity. Result A signature of SDHB genes were identified immune checkpoint and alternative splicing, which showed great value of mechanisms for PPGL. Functional enrichment implied the variation of immune pathways and metallopeptidase activity between expression groups. High- expression group exhibited higher immune score, but lower tumor purity. Finally, we screened sensitive drugs for different risk groups. Conclusion The novel prognostic signature of cuproptosis genes could help risk stratification, immunotherapy response prediction, and individualized treatment strategy-making for glioma patients.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3